<?xml version="1.0" encoding="UTF-8" ?>
<protolog id="rid.8251_nm.1145" type="emendation" xmlns="http://namesforlife.com/ns/protolog" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://namesforlife.com/ns/protolog file:/C:/NamesforLife/workspace/namesforlife-schema/protolog.xsd"><organism doi="10.1601/nm.1145" exemplar-doi="10.1601/ex.1312" rank="species">Ruegeria atlantica</organism><reference id="rid.8251"><citation citation-type="journal"><authors><person-name><surname>Vandecandelaere</surname><given-names>I.</given-names></person-name><person-name><surname>Nercessian</surname><given-names>O.</given-names></person-name><person-name><surname>Segaert</surname><given-names>E.</given-names></person-name><person-name><surname>Achouak</surname><given-names>W.</given-names></person-name><person-name><surname>Faimali</surname><given-names>M.</given-names></person-name><person-name><surname>Vandamme</surname><given-names>P.</given-names></person-name></authors><article-title>Ruegeria scottomollicae sp. nov., isolated from a marine electroactive biofilm.</article-title><year>2008</year><volume>58</volume><issue>12</issue><fpage>2726</fpage><lpage>2733</lpage><source id="117">International Journal of Systematic and Evolutionary Microbiology</source><abbrev>Int J Syst Evol Microbiol</abbrev><issn>1466-5026</issn><essn>1466-5034</essn><pub-id pub-id-type="doi">10.1099/ijs.0.65843-0</pub-id><pub-id pub-id-type="pmid">19060048</pub-id></citation></reference><content><p class="title"><s>Emended description of <em>Ruegeria atlantica</em> (Rüger and Höfle 1992) Uchino <em>et al.</em> 1999</s></p><p class="etymology" /><p class="description"><s>The description is as given by Rüger &#x0026; Höfle (1992), Uchino <em>et al.</em> (1998), Martens <em>et al.</em> (2006), Muramatsu <em>et al.</em> (2007) and Yi <em>et al.</em> (2007), but with the following additions.</s><s>Susceptible to cefoxitin (30 μg), vancomycin (30 μg) and streptomycin (25 μg), moderately susceptible to erythromycin (15 μg) and resistant to trimethoprim (1.25 μg), tetracycline (30 μg), gentamicin (10 μg) and clindamycin (2 μg).</s></p></content></protolog>